Showing results (411-420 of 500) with videos related to
Sort By:
Pageof 50
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2001
Inducible costimulator regulates Th2-mediated inflammation, but not Th2 differentiation, in a model of allergic airway diseaseA G Tesciuba, S Subudhi, R P Rother, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1994
Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigenD J Lenschow, A I Sperling, M P Cooke, et al.Clinical Immunology (Orlando, Fla.)|May 16, 2009
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 yearsKevan C Herold, Stephen Gitelman, Carla Greenbaum, et al.Transplantation|October 3, 1999
Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejectionE S Woodle, D Xu, R A Zivin, et al.Transplantation|June 15, 1994
A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivoM L Alegre, L J Peterson, D Xu, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1988
Thymus-dependent and thymus-independent developmental pathways for peripheral T cell receptor-gamma delta-bearing lymphocytesD M Pardoll, B J Fowlkes, A M Lew, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1992
Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expressionE S Woodle, J R Thistlethwaite, L K Jolliffe, et al.The Journal of Experimental Medicine|July 24, 2013
CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell responseMarc Martínez-Llordella, Jonathan H Esensten, Samantha L Bailey-Bucktrout, et al.Proceedings of the National Academy of Sciences of the United States of America|May 2, 2018
Revealing the specificity of regulatory T cells in murine autoimmune diabetesAllyson Spence, Whitney Purtha, Janice Tam, et al.The Journal of Experimental Medicine|February 18, 2009
A novel myelin P0-specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathyCédric Louvet, Beniwende G Kabre, Dan W Davini, et al.Pageof 50